UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Increased by Addison Advisors LLC

Addison Advisors LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 480 shares of the healthcare conglomerate’s stock after purchasing an additional 55 shares during the period. Addison Advisors LLC’s holdings in UnitedHealth Group were worth $281,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. GDS Wealth Management boosted its stake in UnitedHealth Group by 8.9% in the third quarter. GDS Wealth Management now owns 21,539 shares of the healthcare conglomerate’s stock worth $12,593,000 after purchasing an additional 1,761 shares in the last quarter. Catalytic Wealth RIA LLC increased its position in UnitedHealth Group by 8.8% in the 3rd quarter. Catalytic Wealth RIA LLC now owns 9,959 shares of the healthcare conglomerate’s stock valued at $5,823,000 after acquiring an additional 807 shares in the last quarter. Proffitt & Goodson Inc. grew its stake in shares of UnitedHealth Group by 7.1% during the third quarter. Proffitt & Goodson Inc. now owns 1,624 shares of the healthcare conglomerate’s stock valued at $950,000 after purchasing an additional 107 shares during the last quarter. Paragon Capital Management LLC raised its position in UnitedHealth Group by 2.9% in the 3rd quarter. Paragon Capital Management LLC now owns 721 shares of the healthcare conglomerate’s stock worth $422,000 after purchasing an additional 20 shares during the last quarter. Finally, Ridgecrest Wealth Partners LLC increased its stake in shares of UnitedHealth Group by 19.7% in the 3rd quarter. Ridgecrest Wealth Partners LLC now owns 1,052 shares of the healthcare conglomerate’s stock valued at $615,000 after buying an additional 173 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have weighed in on UNH. Robert W. Baird boosted their price objective on UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. Wells Fargo & Company boosted their price objective on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. HSBC cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. Argus upped their price target on UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Finally, Royal Bank of Canada lowered their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $615.53.

UnitedHealth Group Trading Up 1.5 %

NYSE UNH opened at $625.25 on Tuesday. The company has a market cap of $575.41 billion, a PE ratio of 40.73, a PEG ratio of 1.81 and a beta of 0.58. The company has a current ratio of 0.91, a quick ratio of 0.88 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The stock has a 50 day moving average of $581.93 and a 200-day moving average of $545.85.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter last year, the business earned $6.56 EPS. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.34%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.